EpsteināBarr virus vaccine
Ongoing medical research
As of 2024, a vaccine against EpsteināBarr virus was not yet available. The virus establishes latent infection and causes infectious mononucleosis. There is also increasingly more evidence that EBV may be a trigger of multiple sclerosis. It is a dual-tropic virus, meaning that it infects two different host cell types ā in this case, both B cells...